FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Weijer

Research Profile

Living Beings

Concepts & Ideas

Procedures

Geographic Areas

United States

Activities & Behaviors

Disclosure

Co-author Network

Publications

TOP 3
Shazia H Chaudhry; Allan Donner; Martin P Eccles; Jeremy M Grimshaw; Andrew D McRae; Raphael Saginur; Zoë C Skea; Robert F Boruch; Jamie C Brehaut; Charles Weijer; Merrick Zwarenstein; Monica Taljaard
Challenges in the research ethics review of cluster randomized trials: international survey of investigators.
Andrew McRae; Zoe Skea; Monica Taljaard; Charles Weijer; Carol Bennett; Robert Boruch; Jamie C Brehaut; Martin Eccles; Jeremy Grimshaw; Allan Donner
Reporting of patient consent in healthcare cluster randomised trials is associated with the type of study interventions and publication characteristics.
Andrew D McRae; Charles Weijer; Merrick Zwarenstein; Carol Bennett; Robert Boruch; Jamie C Brehaut; Judith Belle Brown; Shazia Chaudhry; Allan Donner; Martin Eccles; Jeremy Grimshaw; Monica Taljaard
Researchers' perceptions of ethical challenges in cluster randomized trials: a qualitative analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Weijer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shazia H Chaudhry; Allan Donner; Martin P Eccles; Jeremy M Grimshaw; Andrew D McRae; Raphael Saginur; Zoë C Skea; Robert F Boruch; Jamie C Brehaut; Charles Weijer; Merrick Zwarenstein; Monica Taljaard
Challenges in the research ethics review of cluster randomized trials: international survey of investigators.
Clinical trials (London, England) 2013;10(2):257-68.
2013: Andrew McRae; Zoe Skea; Monica Taljaard; Charles Weijer; Carol Bennett; Robert Boruch; Jamie C Brehaut; Martin Eccles; Jeremy Grimshaw; Allan Donner
Reporting of patient consent in healthcare cluster randomised trials is associated with the type of study interventions and publication characteristics.
Journal of medical ethics 2013;39(2):119-24.
2013: Andrew D McRae; Charles Weijer; Merrick Zwarenstein; Carol Bennett; Robert Boruch; Jamie C Brehaut; Judith Belle Brown; Shazia Chaudhry; Allan Donner; Martin Eccles; Jeremy Grimshaw; Monica Taljaard
Researchers' perceptions of ethical challenges in cluster randomized trials: a qualitative analysis.
Trials 2013;14():1.
2012: Charles Weijer; Angela White; Jamie C Brehaut; Martin P Eccles; Jeremy M Grimshaw; Andrew D McRae; Monica Taljaard
The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials.
PLoS medicine 2012;9(11):e1001346.
2012: Antonio Gallo; Jeremy Grimshaw; Andrew D McRae; Raphael Saginur; Robert Boruch; Jamie C Brehaut; Allan Donner; Martin P Eccles; Charles Weijer; Angela White; Merrick Zwarenstein; Monica Taljaard
What is the role and authority of gatekeepers in cluster randomized trials in health research?
Trials 2012;13():116.
2011: Ariella Binik; Charles Weijer; Mark Sheehan
Minimal risk remains an open question.
The American journal of bioethics : AJOB 2011;11(6):25-7.
2011: N M Ivers; A McRae; Z Skea; J Taleban; Monica Taljaard; Charles Weijer; Merrick Zwarenstein; C Bennett; Robert F Boruch; Jamie C Brehaut; S Dixon; Martin P Eccles; Jeremy Grimshaw; Allan Donner
Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8.
BMJ (Clinical research ed.) 2011;343():d5886.
2011: Andrew D McRae; Raphael Saginur; Charles Weijer; Angela White; Ariella Binik; Robert Boruch; Jamie C Brehaut; Allan Donner; Martin P Eccles; Jeremy M Grimshaw; Monica Taljaard
When is informed consent required in cluster randomized trials in health research?
Trials 2011;12():202.
2011: Andrew D McRae; Raphael Saginur; Charles Weijer; Angela White; Merrick Zwarenstein; Ariella Binik; Robert Boruch; Jamie C Brehaut; Allan Donner; Martin P Eccles; Jeremy M Grimshaw; Monica Taljaard
Who is the research subject in cluster randomized trials in health research?
Trials 2011;12():183.
2011: Ariella Binik; Robert Boruch; Jamie C Brehaut; Allan Donner; Martin P Eccles; Jeremy M Grimshaw; Andrew D McRae; Raphael Saginur; Monica Taljaard; Charles Weijer; Merrick Zwarenstein
Does clinical equipoise apply to cluster randomized trials in health research?
Trials 2011;12():118.
2011: Charles Weijer; Jeremy M Grimshaw; Monica Taljaard; Ariella Binik; Robert Boruch; Jamie C Brehaut; Allan Donner; Martin P Eccles; Antonio Gallo; Andrew D McRae; Raphael Saginur; Merrick Zwarenstein
Ethical issues posed by cluster randomized trials in health research.
Trials 2011;12():100.
2010: Charles Weijer
Commentary: Ethics in conduct of trials in developing countries.
BMJ (Clinical research ed.) 2010;340():c1373.
2009: Kate Read; Conrad V Fernandez; Jun Gao; Caron Strahlendorf; Albert Moghrabi; Rebecca Davis Pentz; Raymond Carlton Barfield; Justin Nathaniel Baker; Darcy Santor; Charles Weijer; Eric Kodish
Decision-making by adolescents and parents of children with cancer regarding health research participation.
Pediatrics 2009;124(3):959-65.
2009: Jonathan Kimmelman; Charles Weijer; Eric M Meslin
Helsinki discords: FDA, ethics, and international drug trials.
Lancet 2009;373(9657):13-4.
2007: Charles Weijer; Paul B Miller
Evaluating benefits and harms in intensive care research.
Intensive care medicine 2007;33(10):1819-22.
2007: Charles Weijer; Paul B Miller
Refuting the net risks test: a response to Wendler and Miller's "Assessing research risks systematically".
Journal of medical ethics 2007;33(8):487-90.
2007: Conrad V Fernandez; D Santor; Charles Weijer; C Strahlendorf; Albert Moghrabi; Rebecca D Pentz; J Gao; Eric Kodish
The return of research results to participants: pilot questionnaire of adolescents and parents of children with cancer.
Pediatric blood & cancer 2007;48(4):441-6.
2007: Paul B Miller; Charles Weijer
Equipoise and the duty of care in clinical research: a philosophical response to our critics.
The Journal of medicine and philosophy 2007;32(2):117-33.
2006: Conrad V Fernandez; Charles Weijer
Obligations in offering to disclose genetic research results.
The American journal of bioethics : AJOB 2006;6(6):44-6; author reply W10-2.
2006: Paul B Miller; Charles Weijer
Trust based obligations of the state and physician-researchers to patient-subjects.
Journal of medical ethics 2006;32(9):542-7.
2006: Charles Weijer; Guy J Leblanc
The balm of Gilead: is the provision of treatment to those who seroconvert in HIV prevention trials a matter of moral obligation or moral negotiation?
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2006;34(4):793-808.
2006: Paul B Miller; Charles Weijer
Fiduciary obligation in clinical research.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2006;34(2):424-40.
2005: Charles Weijer
Meaningful work as due inducement.
Theoretical medicine and bioethics 2005;26(5):431-5.
2004: Charles Weijer
The quest for legitimacy: comment on Cox Macpherson's 'To strengthen consensus, consult the stakeholders'.
Bioethics 2004;18(3):293-300.
2004: Charles Weijer; Paul B Miller
When are research risks reasonable in relation to anticipated benefits?
Nature medicine 2004;10(6):570-3.
2004: Conrad V Fernandez; Chris Skedgel; Charles Weijer
Considerations and costs of disclosing study findings to research participants.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;170(9):1417-9.
2004: Charles Weijer
The ethical analysis of risk in intensive care unit research.
Critical care (London, England) 2004;8(2):85-6.
2004: Charles Weijer; Karen Kreiner
Heads or tails: randomized placebo-controlled trials.
The virtual mentor : VM 2004;6(11):.
2004: Charles Weijer; Paul B Miller
Protecting communities in pharmacogenetic and pharmacogenomic research.
The pharmacogenomics journal 2004;4(1):9-16.
2003: Paul B Miller; Charles Weijer
Will the real Charles Fried please stand up?
Kennedy Institute of Ethics journal 2003;13(4):353-7.
2003: Conrad V Fernandez; Eric Kodish; Charles Weijer
Importance of informed consent in offering to return research results to research participants.
Medical and pediatric oncology 2003;41(6):592-3.
2003: Conrad V Fernandez; Eric Kodish; susan shurin; Charles Weijer
Offering to return results to research participants: attitudes and needs of principal investigators in the Children's Oncology Group.
Journal of pediatric hematology/oncology 2003;25(9):704-8.
2003: Paul B Miller; Charles Weijer
Rehabilitating equipoise.
Kennedy Institute of Ethics journal 2003;13(2):93-118.
2003: Charles Weijer
The ethics of placebo-controlled trials.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(6):1150-3.
2003: Conrad V Fernandez; Eric Kodish; Shaureen Taweel; susan shurin; Charles Weijer
Disclosure of the right of research participants to receive research results: an analysis of consent forms in the Children's Oncology Group.
Cancer 2003;97(11):2904-9.
2003: Conrad V Fernandez; Eric Kodish; Charles Weijer
Informing study participants of research results: an ethical imperative.
IRB 2003;25(3):12-9.
2003: Charles Weijer; Paul B Miller
Therapeutic obligation in clinical research.
The Hastings Center report 2003;33(3):3.
2003: Charles Weijer; Akira Akabayashi
Unethical author attribution.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 2003;12(1):124-30.
2002: Charles Weijer
Continuing review of clinical research Canadian-style.
Clinical and investigative medicine. Médecine clinique et experimentale 2002;25(3):92-3.
2002: Andrew D McRae; Charles Weijer
Lessons from everyday lives: a moral justification for acute care research.
Critical care medicine 2002;30(5):1146-51.
2002: Charles Weijer
Placebo trials and tribulations.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(5):603-4.
2002: Charles Weijer; Kathleen Cranley Glass
The ethics of placebo-controlled trials.
The New England journal of medicine 2002;346(5):382-3.
2002: Charles Weijer; James A Anderson
A critical appraisal of protections for aboriginal communities in biomedical research.
Jurimetrics 2002;42(2):187-98.
2002: James A Anderson; Charles Weijer
The research subject as wage earner.
Theoretical medicine and bioethics 2002;23(4-5):359-76.
2002: Charles Weijer
I need a placebo like I need a hole in the head.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2002;30(1):69-72.
2001: J A Anderson; Charles Weijer
Minimal risk and its implications. Proceedings of the NCEHR National Workshop on Minimal Risk, March 31-April 1, 2000 held in Ottawa, Ontario, Canada.
NCEHR communiqué = Communiqué CNERH 2001;11(1):15-26.
2001: Charles Weijer
Continuing review of research approved by Canadian research ethics boards.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;164(9):1305-6.
2001: Peter A Singer; G Barker; K W Bowman; C Harrison; P Kernerman; J Kopelow; N Lazar; Charles Weijer; S Workman
Hospital policy on appropriate use of life-sustaining treatment. University of Toronto Joint Centre for Bioethics/Critical Care Medicine Program Task Force.
Critical care medicine 2001;29(1):187-91.
2000: Charles Weijer
Benefit-sharing and other protections for communities in genetic research.
Clinical genetics 2000;58(5):367-8.
2000: Charles Weijer; Stanley H Shapiro; K Cranley Glass
For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial.
BMJ (Clinical research ed.) 2000;321(7263):756-8.
2000: Paul B Miller; Charles Weijer
Moral solutions in assessing research risk.
IRB 2000;22(5):6-10.
2000: Charles Weijer; E J Emanuel
Ethics. Protecting communities in biomedical research.
Science (New York, N.Y.) 2000;289(5482):1142-4.
2000: Charles Weijer
The ethical analysis of risk.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2000;28(4):344-61.
1999: Charles Weijer; G Goldsand; E J Emanuel
Protecting communities in research: current guidelines and limits of extrapolation.
Nature genetics 1999;23(3):275-80.
1999: Charles Weijer
The analysis of risks and potential benefits in research.
NCEHR communiqué = Communiqué CNERH 1999;9(2):16-20.
1999: Kathleen Cranley Glass; Charles Weijer; Denis Cournoyer; Trudo Lemmens; Roberta Palmour; Stanley H Shapiro; Benjamin Freedman
Structuring the review of human genetics protocols, part III: gene therapy studies.
IRB 1999;21(2):1-9.
1999: Charles Weijer
Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary?
Schizophrenia research 1999;35(3):211-8; discussion 227-36.
1999: Charles Weijer
Selecting subjects for participation in clinical research: one sphere of justice.
Journal of medical ethics 1999;25(1):31-6.
1999: Charles Weijer; R A Crouch
Why should we include women and minorities in randomized controlled trials?
The Journal of clinical ethics 1999;10(2):100-6.
1999: Charles Weijer
Protecting communities in research: philosophical and pragmatic challenges.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 1999;8(4):501-13.
1998: Myrian Skrutkowski; Charles Weijer; Stan Shapiro; Abraham Fuks; Adrian Langleben; Benjamin Freedman
Monitoring informed consent in an oncology study posing serious risk to subjects.
IRB 1998;20(6):1-6.
1998: Charles Weijer; Benjamin Freedman; S Shapiro; Abraham Fuks; M Skrutkowska; M Sigurjonsdottir
Assessing the interpretation of criteria for clinical trial eligibility: a survey of oncology investigators.
Clinical and investigative medicine. Médecine clinique et experimentale 1998;21(1):17-26.
1997: Kathleen Cranley Glass; Charles Weijer; Trudo Lemmens; Roberta Palmour; Stanley H Shapiro
Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.
IRB 1997;19(3-4):1-13.
1996: Kathleen Cranley Glass; Charles Weijer; Roberta Palmour; Stanley H Shapiro; Trudo Lemmens; Karen Lebacqz
Structuring the review of human genetics protocols: gene localization and identification studies.
IRB 1996;18(4):1-9.
1996: Charles Weijer; Benjamin Freedman; Abraham Fuks; J Robbins; S Shapiro; M Skrutkowska
What difference does it make to be treated in a clinical trial? A pilot study.
Clinical and investigative medicine. Médecine clinique et experimentale 1996;19(3):179-83.
1996: B Freedman; Kathleen Cranley Glass; Charles Weijer
Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 1996;24(3):252-9.
1996: B Freedman; Charles Weijer; Kathleen Cranley Glass
Placebo orthodoxy in clinical research. I: Empirical and methodological myths.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 1996;24(3):243-51.
1996: Charles Weijer
Evolving ethical issues in selection of subjects for clinical research.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 1996;5(3):334-45.
1995: Charles Weijer; S Shapiro; Abraham Fuks; K C Glass; M Skrutkowska
Monitoring clinical research: an obligation unfulfilled.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1995;152(12):1973-80.
1995: Charles Weijer
Learning from the Dutch: physician-assisted death, slippery slopes and the Nazi analogy.
Health law review 1995;4(1):23-9.
1994: Charles Weijer; Abraham Fuks
The duty to exclude: excluding people at undue risk from research.
Clinical and investigative medicine. Médecine clinique et experimentale 1994;17(2):115-22.
1992: B Freedman; Abraham Fuks; Charles Weijer
Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research.
Clinical research 1992;40(4):653-60.